Increasing evidence suggests that targeting OXPHOS in tumour cells may lead to severe mitochondrial dysfunction and energetic crisis, which in turn inhibits cancer cell progression [35, 36].TEFM acts as a mitochondrial transcriptional elongation factor, which is critical for mtDNA transcription, OXPHOS and mitochondrial biological processes. Here, TEFM is linked to neoplasm.